Q4 2024 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2025-02-14 · accession 0001104659-25-013930
$120.2M
Reported value
6
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 022307102 | ALMS | Alumis Inc | $45.4M | 37.8% | 5,779,348 | Common | SOLE |
| 433000106 | HIMS | Hims & Hers Health, Inc. | $22.7M | 18.9% | 939,860 | Common | SOLE |
| 156944100 | CGON | CG Oncology, Inc. | $19.9M | 16.5% | 692,550 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $19.0M | 15.8% | 299,069 | Common | SOLE |
| 230031106 | CGEM | Cullinan Therapeutics Inc | $8.0M | 6.67% | 657,905 | Common | SOLE |
| 55083R104 | — | Lyell Immunopharma Inc | $5.2M | 4.33% | 8,133,047 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.